22.29.Z - Manufacture of rubber and plastic products
26.60.Z - Manufacture of irradiation equipment, electromedical and electrotherapeutic equipment
30.92.Z - Manufacture of bicycles and invalid carriages
32.50.Z - Production of medical devices, instruments, and products, including dental products
32.99.Z - Production of other products not classified elsewhere
46.46.Z - Wholesale trade of pharmaceutical and medical products
47.74.Z - Retail sale of medical and orthopedic products
72.11.Z - Scientific research and development activities
72.19.Z - Scientific research and development activities
2021 | 2022 | 2023 | ||
---|---|---|---|---|
M PLN | M PLN | M PLN | % | |
Profit (loss) on sale | 0,3 | 0,8 | 1,3 | 71,8 |
Gross profit (loss) | 0,4 | 0,8 | 1,4 | 71,4 |
EBITDA | 0,5 | 0,9 | 1,4 | 68,1 |
Short time liabilities | 0,2 | 0,3 | 0,3 | 15 |
Other operating costs | 0 | 0 | 0 | 2102,6 |
Equity capital | 3 | 3,2 | 3,8 | 19,3 |
Operating profit (EBIT) | 0,4 | 0,8 | 1,3 | 70,5 |
Assets | 3,3 | 3,5 | 4,1 | 18,1 |
Net profit (loss) | 0,4 | 0,7 | 1,2 | 71,4 |
Cash | 1 | 1,1 | 1,7 | 52,9 |
Net income from sale | 1,8 | 2,5 | 3,4 | 34,6 |
Liabilities and provisions for liabilities | 0,3 | 0,3 | 0,3 | 5 |
Working assets | 1,8 | 1,7 | 2,4 | 39,8 |
Other income costs | 0,1 | 0 | 0 | 29,1 |
Depreciation | 0,1 | 0,1 | 0,1 | 42,7 |
% | % | % | p.p. | |
Profitability of capital | 13,6 | 22,6 | 32,5 | 9,9 |
Equity capital to total assets | 91,4 | 91,9 | 92,8 | 0,9 |
Gross profit margin | 23,9 | 31,2 | 39,7 | 8,5 |
EBITDA Margin | 28 | 33,9 | 42,3 | 8,4 |
Days | Days | Days | Days | |
Short term commitment turnover cycle | 42 | 37 | 32 | -5 |
Current financial liquidity indicator | 8.355684280395508 | 6.773431301116943 | 8.237568855285645 | 1,4 |
Net dept to EBITDA | -1.8932267427444458 | -1.2413588762283325 | -1.154808759689331 | 0 |
Opinie dotyczące usług, produktów oraz działalności firmy nie są weryfikowane